Research

The Memory Disorders Center is committed to advancing treatments that offer the best possible outcomes for patients with Alzheimer’s disease and other causes of cognitive impairment. In 2011 the Center began enrolling patients in its first clinical trial, and plans are underway to continue to expand opportunities for people eager to participate in clinical research.

Future studies will likely explore:

• the implementation of new diagnostic tests
• new medications
• the potential for lifestyle modifications to impact cognitive health
• the clinical impact of memory disorders upon quality of life

Collaboration with our partners at other centers within UCNI has already improved our understanding of these diseases. By working closely with other clinical and laboratory experts, the Memory Disorders Center will continue to offer the most innovative, effective and compassionate care.

A list of current studies appears below. For more information, please click on the link to contact the coordinator.

UC Clinical Trials

Clinical Study Protocol CENA713D US44
A 24-Week, Prospective, Randomized, Parallel-Group, Double-Blind, Multi-Center Study Comparing the Effects of Rivastigmine Patch 15 cm2 vs. Rivastigmine Patch 5 cm2 on Activities of Daily Living and Cognition in Patients with Severe Dementia of the Alzheimer’s Type
Funded by: Novartis
Principal Investigator: Brendan Kelley, MD, MS
Coordinator Lori Scott: (513) 475-7820 or scottlj@ucphysicians.com

.